Literature DB >> 3335748

The effect of age on serum albumin in healthy males: report from the Normative Aging Study.

E W Campion1, L O deLabry, R J Glynn.   

Abstract

To clarify the relation between age and serum albumin, measures were obtained on a screened population of 1066 healthy males in the Normative Aging Study. Multiple regression analysis shows only a slight decline in albumin of 0.054 gm/dl per decade with R = -0.12 (p less than .001) on cross-sectional data. This small decline occurs entirely within the range of normal, contrary to many previous reports. Mean albumin values were 4.25 (+/- .26 SD) for subjects in the eighth decade and 4.13 (+/- .29 SD) in the ninth decade. Longitudinally, there was an upwards trend in albumin for five birth cohorts over an 8-yr period which may reflect laboratory drift. A multivariate model of cross-sectional data can explain only 5% of the variance. The age-related decline within healthy subjects is far less than previously described. Our data demonstrate that hypoalbuminemia is not a consequence of normal aging.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335748     DOI: 10.1093/geronj/43.1.m18

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  19 in total

1.  Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 3.  [Limits and relevance of the laboratory diagnosis of malnutrition in the elderly].

Authors:  Alexander Lapin
Journal:  Wien Med Wochenschr       Date:  2006-03

4.  The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein.

Authors:  B T Veering; A G Burm; J H Souverijn; J M Serree; J Spierdijk
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

Review 5.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

6.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

7.  Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.

Authors:  Felix Stader; Marco Siccardi; Manuel Battegay; Hannah Kinvig; Melissa A Penny; Catia Marzolini
Journal:  Clin Pharmacokinet       Date:  2019-04       Impact factor: 6.447

8.  Analyses of laboratory data and establishment of reference values and intervals for healthy elderly people.

Authors:  K Kubota; T Kadomura; K Ohta; K Koyama; H Okuda; M Kobayashi; C Ishii; Y Fujiwara; T Nishiora; Y Ohmae; T Ohmae; M Kitajima
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

Review 9.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

10.  Gender-specific liver aging and magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.